The deficiency of erythrocyte NADH-methaemoglobin reductase has been documented in many other patients with congenital methaemoglobinaemia and reviewed by Hsieh and Jaffe (1975) . Recently, many investigators have considered NADH-cytochrome b5 reductase to be the major enzyme catalysing the reduction of methaemoglobin in vivo and hereditary methaemoglobinaemia to be due to an abnormality of this enzyme (Hultquist and Passon, 1971; Sugita et al., 1971 ; Kuma and Inomata, 1972) . In general, the patients encounter little difficulty although they have slate-grey cyanosis. However, Dine (1956) found congenital methaemoglobinaemia with mental retardation. Recently, it has been evident that a small but significant number have mental retardation, and the early detection of hereditary methaemoglobinaemia in the newborn has been of great value (Fialkow et al., 1965 ; Leroux et al., 1975) .
Methaemoglobin reductase activity in red blood cells is generally measured as 'diaphorase' by using Received for publication 18 September 1978 the dye 2,6-dichlorophenolindophenol (DCIP) as an electron acceptor. However, diaphorase is resolved into various fractions by ion-exchange chromatography, and only one of these fractions shows the activity of cytochrome b5 reductase. For this reason it is most satisfactory to measure the cytochrome b5 reductase activity for the specific diagnosis of hereditary methaemoglobinaemia. With regard to the assay of cytochrome b5 reductase, it is difficult and time-consuming to prepare cytochrome b5 as a terminal electron acceptor from tissue sources. We reported previously the ferricyanide reductase assay substituted for the cytochrome b5 reductase assay, which had the advantage of using a chemical reagent as substrate electron acceptor and specificity for cytochrome b5 reductase activity, but involved excluding haemoglobin from the haemolysate using a CM-cellulose column I (Tanishima et al., 1978) .
The purpose of this report is to describe exclusion of interference by haemoglobin with the absorption by potassium ferricyanide at 420 nm using a continuous-flow dialysing system, and to establish a simple and rapid automated assay for screening hereditary methaemoglobinaemia. 584 where E = the difference in absorption between ferricyanide and distilled water at 420 nm, V = volume of reaction mixture = 1 6 ml, t = reaction time = 2 minutes, Ht = haematocrit value (%), v = volume of blood sample = 0-01 ml, 1020 = molar extinction coefficient of potassium ferricyanide at 420 nm.
The limit of resolution for the difference between total and unreacted substrates (4 substrate) was 15 nmol per minute, when a diluted solution of the purified enzyme was assayed with the AutoAnalyzer instrumentation using potassium ferricyanide as an electron acceptor (z OD was 0-01 in spectrophotometry).
DETERMINATION OF HAEMATOCRIT VALUE
The haematocrit value was determined according to the microhaematocrit method using the Haematocrit centrifuge RC-24BN (Tomy Seiko Co. Ltd) at 11 000 rpm for 5 minutes.
Waste MANUAL METHODS FOR MEASURING REDUCTASE ACTIVITY
NADH-ferricyanide reductase activity of a partially purified enzyme from normal red cells and NADHdiaphorase activity of a haemolysate using 2,6-dichlorophenolindophenol as an electron acceptor were assayed according to the methods reported previously by Tanishima et al. (1978) . In this report, linearity, effect of pH and kinetics of ferricyanide reductase activity were studied.
PURIFIED CYTOCHROME b5 REDUCTASE Cytochrome b5 reductase for use in fundamental studies and quality control was purified from normal human red cell haemolysate by DE-32 column chromatography as reported previously (Tanishima et al., 1978) .
Results

STUDIES ON FUNDAMENTAL PROBLEMS
Linearity for ferricyanide reductase activity in both the manual reference method and the automated test method were studied by assaying the enzyme purified from normal red cell haemolysate (Fig. 2) Figure 5 .
It can be seen in the results from both the automated method and the diaphorase method that the values of activity in cord blood are significantly lower than those in adult blood. Only a little overlapping of the values in cord blood with those in adult blood is observed for ferricyanide reductase activity in the test method. In the diaphorase system, however, a certain overlapping between the values from these two blood groups is seen.
The mean ferricyanide reductase activity of blood samples from 23 normal adults was 4 0 ± 063 IU per ml of erythrocytes, and that from 14 cord bloods was 1-95 ± 0 43 IU per ml of erythrocytes. In the blood sample from a patient with hereditary methaemoglobinaemia, the ferricyanide reductase activity was 0-56 IU per ml of erythrocytes.
APPLICATION TO SCREENING
Ferricyanide reductase activities of 1466 human blood samples from our hospital were analysed by our automated test method. Figure 6 shows the distribution of the values. From the linearity in plotting cumulative frequency on probability paper, it was evident that these values of ferricyanide reductase activities were quasi-Gaussian.
Discussion
Since Gibson (1948) and Scott and Griffith (1959) reported a congenital deficiency of an enzyme catalysing the reduction of methaemoglobin in erythrocytes, it has been an important problem to determine the methaemoglobin reductase activity for the detection of this disease. Various methods have been reported for determining reductase activity, for example, the diaphorase method by Scott (1960) , the cytochrome b5 reductase method by Hultquist and Passon (1971) , and the ferrihaemoglobin reductase method by Hegesh et al. (1968) . The ferricyanide reductase method previously described by us (Tanishima et al., 1978) not only correlated well with accepted methods but also met the requirement of a simple and specific test for the diagnosis of hereditary methaemoglobinaemia, because of its easy application to routine work in the laboratory without any special reagents or expensive equipment.
Results by the automated method offer more rapid analysis and mass screening of the enzyme deficiency in hereditary methaemoglobinaemia. The screening of hereditary methaemoglobinaemia is important for the early detection of the disease and its prevention in infants. Previous observations record that a small but significant proportion of the cases of congenital enzymopenic methaemoglobinaemia is associated with a progressive neurological disorder with mental retardation causing death at a young age (Leroux et al., 1975) . The detection of heterozygous carriers is a problem because this inheritance is considered to be a simple recessive trait. We used cord blood to simulate heterozygotes. We believe we are justified in this because heterozygous carriers have methaemoglobin reductase levels about half those of normals (Scott, 1960) , and also red cells from cord blood are thought to be weak in their ability to reduce methaemoglobin because of the lower reductase activity in such cells -about half normal levels (Hegesh et al., 1968; Ross, 1963; Vetrella et al., 1971; Kanazawa et al., 1968) . Kaplan et al. (1970) reported a simple spot screening test for the fast detection of red cell NADHdiaphorase deficiency. Their results obtained with heterozygous subjects were not clearcut, and they do not recommend this test for the detection of heterozygotes. The suitability of our method for the detection of the heterozygous trait is suggested by its ability to discriminate better than the standard diaphorase method between cord blood and blood from adults (Fig. 5) . The use of the AutoAnalyzer is also an advantage of the method and contributes. The population screened in this investigation ranged from 19 to 71 years of age and few of these subjects had low ferricyanide reductase activity. Two whose blood showed the lowest enzyme activity have, respectively, hypertension treated with trichlormethiazide (Fluitran), hydrallazine (Apresolin), and methoserpidine (Decaserpyl) (59 years old), and hepatoma with pulmonary metastasis (71 years old). However, any possible relation between these diseases or therapy and a lower methaemoglobin reductase activity in red blood cells is obscure.
In contrast with the result obtained from adult blood, the detection of the heterozygote in children remains a problem. Detection of the heterozygote in cord and infant blood is very difficult but may become possible by increasing the sensitivity of the method. It should be further investigated in order to measure the reduction rate by the enzyme at 340 nm, the maximum absorption wavelength for NADH, in place of 420 nm for potassium ferricyanide.
